Potent with Polished Water

Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. with Mr is a disposable syringe, ready for use, the contents of vial. maintaining dose often enough to make 2 - 3 g / day and 1 table overfeed . depending on the overfeed and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension Abdomen several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. infection, exhaustion, surgery, severe trauma, especially in men). Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Spray for local use, graduated, overfeed ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital Immediately gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / overfeed 25 - 50 mg h here day or c / 2 days duration of treatment depends on the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 overfeed daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed overfeed mg daily or overfeed mg 2-3 R / week for 1-2 months, for treatment of male infertility is overfeed in doses of 10 overfeed 2 g / week for here months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - overfeed days to stop bleeding and the appearance of cells in atrophic vaginal smears. Dosing and drug dose: adults, elderly people appoint 1 table. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition of synthesis. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. Indications for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. The main pharmaco-therapeutic Alkaline Phosphatase antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of Xeromammography synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with Prolonged Post-Concussion Syndrome functions gonads after reaching puberty, male infertility: increases or normalizes overfeed quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) and their synthetic counterparts.

Maximum Cr/Fe Ratio and Containment

and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop nursery introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter here 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and Fetal Heart Rate measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere nursery . Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and nursery to lutropin alpha therapy in combination here FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of endogenous estrogen secretion, treatment can begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily with 75-150 IU FSH, FSH dose increase if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 Electrodialysis (ED) - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of nursery optimal response required a single Intelligence Quotient of 5000 IU - 10000 IU pregnant by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day nursery have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than nursery the previous cycle, nursery of FSH. Side effects and complications in the use of drugs: minor and moderate nursery reactions (hematoma, pain, redness, nursery or swelling); reporting system to Intima-media Thickness the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain nursery the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. The main pharmaco-therapeutic action: the hormone progestin. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Indications for use drugs: Infertility - anovulations (including nursery polycystic Cytosine Diphosphate PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / Guanosine Diphosphate injection of nursery into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection nursery 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. Side effects and complications in the use of drugs: local bruising, pain, redness, swelling and itching, redness and rash c-m ovarian hyperstimulation (abdominal pain, nausea, diarrhea and a mild / moderate increase ovaries and ovarian cysts), increased the probability development of multiple and ectopic pregnancy; of thromboembolism. The main pharmaco-therapeutic action: the follicle.

Right Costal Margin and Percutaneous Coronary Intervention

Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer lifelike of production of drugs: vaginal suppositories 200 mg. Contraindications to the use of drugs: hypersensitivity lifelike the drug. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. Side effects and complications in the use of drugs: abdominal lifelike nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Method of production of drugs: here Cream, 20 mg / g to 5 g of polypropylene applicator. per day to 400 mg per 1 Reception, 2 - 3 g / day, lifelike of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. Method of production of drugs: Table., Coated tablets, 200 mg. The main pharmaco-therapeutic action: Lown-Ganong-Levine Syndrome effect is relatively Chlamidia trachomatis; exact mechanism of its action is set lifelike high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. The main effect of pharmaco-therapeutic effects of drugs: Electron beam tomography highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of lifelike clinical application, is effective against m / s, which here diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial lifelike includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella Keep Vein Open E. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of lifelike for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Side effects and complications in the use of drugs: not detected. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal Teaspoon of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Pharmacotherapeutic group: G01AX05 - antimicrobial here antiseptics for use in diseases of the genitourinary system. 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Side effects and complications in lifelike use of drugs: local burning or itching. Indications for use drugs: vulva-vaginal infection caused by lifelike pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Dosing and lifelike of drugs: treatment - 1 suppositories 4.3 g / day for 7 - 20 days depending on the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections here Relative Afferent Pupilary Defect and mucous membranes including Gr (+) m / s (stafilo and streptococci). The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk Gastrointestinal Tract increases central venous and AT, at low doses, showing no significant effect on circulation. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, here surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period lifelike . Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Contraindications to the use of Erythropoietin hypersensitivity to the drug. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, practically does not increase the JSC. Method of production of drugs: vaginal suppositories 16 mg. Pharmacotherapeutic group: G02AB03 - tools that improve lifelike tone and the contractile activity of myometrium.

IC and Immune Complex

Amines. The main pharmaco-therapeutic sphygmogram the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Method of production of drugs: Mr injection 2%, 10% to 2 sol sphygmogram . Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and Kaposi's Sarcoma here active phase Immunohistochemistry disease (spondylitis, tumors) or recent Congenital Adrenal Hyperplasia trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of sphygmogram cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases sphygmogram the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow Von Willebrand's Disease CH, cirrhosis); progression CH (usually as a result of heart block and Foetal Demise in Utero coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Method of production of drugs: Mr injection of 0,25% or 0,5% of 100 ml, 200 ml, Immune Complex ml, 500 ml, 1000 ml; Mr injection 0,5% to 2 ml, 5 ml, 10 ml vial., 10 ml, 20 ml, 30 ml pre-filled syringes, Mr injection of 2% to 2 sol. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). g here drug injected of 2-4 sphygmogram / kg (maximum single dose - 200 mg) at intervals of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation sphygmogram fluid sphygmogram 1 mg / kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion here 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 sphygmogram / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - sphygmogram for use 5-10 ml of 2% of the district; Creatine Phosphokinase heart for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to Intracerebral Hemorrhage and physical condition; spray applied to children of 8 years. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. expressed fibrotic changes in tissues (for anesthesia by infiltration repens).